Netherlands· NL-832845369bcb
Ziagen 20 mg/ml, drank
A abacavir product containing abacavirsulfaat, registered in Netherlands by ViiV healthcare B.V.. The same ATC class is registered in 16 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Abacavir is registered in 16 of 19 countries.
Countries holding a registration under ATC J05AF06 (abacavir), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 10 of them publish a price we can compare per daily dose
Abacavir · ATC J05AF06
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of abacavir costs, country by country.
Normalised to the WHO defined daily dose (0.6 g), the median price runs from $3.98 in France to $9.36 in Switzerland — a ×2.3 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Abacavir · price per daily dose (0.6 g)
USD · FX 28 Sept 2026
- CH Switzerland$9.36
- FR France$3.98
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- ABACAVIRSULFAAT
- Manufacturer
- ViiV healthcare B.V.
- Country
- Netherlands (NL)
- ATC code
- J05AF06
- ATC class
- Abacavir
- Defined daily dose
- 0.6 g, O
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_idEU/1/99/112
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
131 interactions on record for abacavir.
Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Abacavir · interactions on record
131 records
- 4 severe
- 23 moderate
- 6 minor
- 96 info
Most severe, free to view
- LeflunomidL04AA13severe
- TeriflunomidL04AA31severe
- LeflunomideL04AK01severe
- TeriflunomideL04AK02severe
2 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Abacavir in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesAbacavirRising Pharma Holdings, Inc.
- CzechiaZIAGENViiV Healthcare BV, Amersfoort
- SpainZIAGEN 20 MG/ML SOLUCION ORALViiv Healthcare B.V.
- FinlandZiagenViiV Healthcare BV
- FranceZIAGEN 20 mg/ml, solution buvableVIIV HEALTHCARE UK (ROYAUME-UNI)
- BelgiumZiagen 20 mg/mlViiV Healthcare
- IcelandZiagenViiV Healthcare BV
- NorwayZiagenUkjent (2)
Authorised across Europe · EMA
The same active substance is authorised in 10 EEA countries. Names it is sold under:
- Spain · Abacavir Tarbis
- Finland · Abacavir Accord
- France · Abacavir Arrow, Abacavir Sandoz
- United Kingdom (Northern Ireland) · Abacavir Milpharm, Abacavir Mylan
- Iceland · Ziagen
- Italy · Abacavir Mylan
- Liechtenstein · Ziagen
- Norway · Ziagen
- Portugal · Abacavir Farmoz, Abacavir Generis
- Romania · Abacavir Aurobindo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a53f64b0-312c-409e-b169-0047b6be2d55 GET /v1/drugs/a53f64b0-312c-409e-b169-0047b6be2d55?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Drank",
"route": "Oraal gebruik",
"soort": null,
"source": "cbg_meb",
"smpc_url": "https://www.ema.europa.eu/en/documents/product-information/ziagen-epar-product-information_nl.pdf",
"strength": null,
"atc_label": "Abacavir",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp70521",
"excipients": [
"BANANA FLAVOUR 59.256 AP 05.51 (RI)",
"CITROENZUUR 0-WATER (E 330)",
"GLYCEROLTRIACETAAT (E 1518)",
"MALTODEXTRINE",
"MALTODEXTRINE",
"MELKZUUR (E 270)",
"METHYLPARAHYDROXYBENZOAAT (E 218)",
"NATRIUMHYDROXIDE (E 524)",
"PROPYLEENGLYCOL (E 1520)",
"PROPYLEENGLYCOL (E 1520)",
"PROPYLEENGLYCOL (E 1520)",
"PROPYLPARAHYDROXYBENZOAAT",
"SACCHAROIDE NATRIUM X-WATER (E 954)",
"SORBITOL, VLOEIBAAR, NIET-KRISTALLISEERBAAR (E 420)",
"STRAWBERRY FLAVOUR 57.883 / AP 05.51 (RI)",
"TRINATRIUMCITRAAT 2-WATER (E 331)",
"WATER, GEZUIVERD",
"ZOUTZUUR (E 507)"
],
"substances": [
"ABACAVIRSULFAAT"
],
"leaflet_url": null,
"authorised_at": "1999/07/08",
"procedure_number": "EMEA/H/C/000252",
"dispensing_status": "Uitsluitend recept",
"registration_number": "EU/1/99/112",
"additional_monitoring": "N"
}See everything about abacavir.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.